nodes	percent_of_prediction	percent_of_DWPC	metapath
Levothyroxine—CYP3A4—Temozolomide—brain cancer	0.0873	0.344	CbGbCtD
Levothyroxine—CYP3A4—Lomustine—brain cancer	0.0742	0.293	CbGbCtD
Levothyroxine—TTR—choroid plexus—brain cancer	0.054	0.145	CbGeAlD
Levothyroxine—CYP2C8—Etoposide—brain cancer	0.0442	0.174	CbGbCtD
Levothyroxine—ABCB1—Etoposide—brain cancer	0.0299	0.118	CbGbCtD
Levothyroxine—Infertility—Procarbazine—brain cancer	0.0227	0.0791	CcSEcCtD
Levothyroxine—CYP3A4—Etoposide—brain cancer	0.0179	0.0707	CbGbCtD
Levothyroxine—SERPINA7—hindbrain—brain cancer	0.0163	0.0436	CbGeAlD
Levothyroxine—Infertility—Carmustine—brain cancer	0.0142	0.0495	CcSEcCtD
Levothyroxine—Infertility—Temozolomide—brain cancer	0.0137	0.0478	CcSEcCtD
Levothyroxine—TTR—pineal body—brain cancer	0.0137	0.0368	CbGeAlD
Levothyroxine—SLCO1C1—ganglion—brain cancer	0.011	0.0295	CbGeAlD
Levothyroxine—THRB—hindbrain—brain cancer	0.01	0.0269	CbGeAlD
Levothyroxine—THRA—hindbrain—brain cancer	0.01	0.0269	CbGeAlD
Levothyroxine—Disorientation—Lomustine—brain cancer	0.00757	0.0264	CcSEcCtD
Levothyroxine—TTR—hindbrain—brain cancer	0.00746	0.02	CbGeAlD
Levothyroxine—SLC7A5—Basigin interactions—BSG—brain cancer	0.0061	0.0703	CbGpPWpGaD
Levothyroxine—SERPINA7—spinal cord—brain cancer	0.00579	0.0155	CbGeAlD
Levothyroxine—THRB—brainstem—brain cancer	0.00575	0.0154	CbGeAlD
Levothyroxine—THRA—brainstem—brain cancer	0.00575	0.0154	CbGeAlD
Levothyroxine—Coma—Procarbazine—brain cancer	0.00541	0.0189	CcSEcCtD
Levothyroxine—SERPINA7—endocrine gland—brain cancer	0.00521	0.014	CbGeAlD
Levothyroxine—THRA—telencephalon—brain cancer	0.00511	0.0137	CbGeAlD
Levothyroxine—Disorientation—Procarbazine—brain cancer	0.0048	0.0167	CcSEcCtD
Levothyroxine—SERPINA7—central nervous system—brain cancer	0.0047	0.0126	CbGeAlD
Levothyroxine—SERPINA7—cerebellum—brain cancer	0.00459	0.0123	CbGeAlD
Levothyroxine—TTR—brainstem—brain cancer	0.00428	0.0115	CbGeAlD
Levothyroxine—THRB—gonad—brain cancer	0.00426	0.0114	CbGeAlD
Levothyroxine—THRA—gonad—brain cancer	0.00426	0.0114	CbGeAlD
Levothyroxine—SLCO1C1—telencephalon—brain cancer	0.00425	0.0114	CbGeAlD
Levothyroxine—SLCO1B3—pituitary gland—brain cancer	0.00421	0.0113	CbGeAlD
Levothyroxine—THRB—pituitary gland—brain cancer	0.00416	0.0112	CbGeAlD
Levothyroxine—Alopecia—Lomustine—brain cancer	0.00414	0.0144	CcSEcCtD
Levothyroxine—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00398	0.0459	CbGpPWpGaD
Levothyroxine—SLC7A5—telencephalon—brain cancer	0.0039	0.0105	CbGeAlD
Levothyroxine—TTR—telencephalon—brain cancer	0.0038	0.0102	CbGeAlD
Levothyroxine—SLC16A2—pituitary gland—brain cancer	0.00377	0.0101	CbGeAlD
Levothyroxine—Disorientation—Hydroxyurea—brain cancer	0.00372	0.013	CcSEcCtD
Levothyroxine—Dysphagia—Procarbazine—brain cancer	0.00371	0.0129	CcSEcCtD
Levothyroxine—SLC16A2—medulla oblongata—brain cancer	0.00364	0.00975	CbGeAlD
Levothyroxine—Angina pectoris—Procarbazine—brain cancer	0.00362	0.0126	CcSEcCtD
Levothyroxine—Sweating increased—Procarbazine—brain cancer	0.00362	0.0126	CcSEcCtD
Levothyroxine—THRA—spinal cord—brain cancer	0.00358	0.0096	CbGeAlD
Levothyroxine—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00358	0.0412	CbGpPWpGaD
Levothyroxine—SLCO1C1—pituitary gland—brain cancer	0.00346	0.00927	CbGeAlD
Levothyroxine—SLCO4A1—telencephalon—brain cancer	0.0034	0.00913	CbGeAlD
Levothyroxine—Coma—Carmustine—brain cancer	0.00339	0.0118	CcSEcCtD
Levothyroxine—SLCO1B3—endocrine gland—brain cancer	0.00327	0.00876	CbGeAlD
Levothyroxine—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00326	0.0375	CbGpPWpGaD
Levothyroxine—SLC7A5—gonad—brain cancer	0.00325	0.00872	CbGeAlD
Levothyroxine—SLC16A2—spinal cord—brain cancer	0.00324	0.00869	CbGeAlD
Levothyroxine—THRB—endocrine gland—brain cancer	0.00322	0.00864	CbGeAlD
Levothyroxine—THRA—endocrine gland—brain cancer	0.00322	0.00864	CbGeAlD
Levothyroxine—THRA—head—brain cancer	0.00318	0.00853	CbGeAlD
Levothyroxine—THRB—head—brain cancer	0.00318	0.00853	CbGeAlD
Levothyroxine—Sweating—Procarbazine—brain cancer	0.00318	0.0111	CcSEcCtD
Levothyroxine—SLC7A5—pituitary gland—brain cancer	0.00317	0.00851	CbGeAlD
Levothyroxine—TTR—pituitary gland—brain cancer	0.00309	0.00829	CbGeAlD
Levothyroxine—SLC7A5—medulla oblongata—brain cancer	0.00306	0.00821	CbGeAlD
Levothyroxine—SLCO1C1—midbrain—brain cancer	0.00305	0.00818	CbGeAlD
Levothyroxine—Body temperature increased—Carboplatin—brain cancer	0.00301	0.0105	CcSEcCtD
Levothyroxine—TTR—medulla oblongata—brain cancer	0.00298	0.008	CbGeAlD
Levothyroxine—SLCO1C1—spinal cord—brain cancer	0.00297	0.00798	CbGeAlD
Levothyroxine—SLC16A2—endocrine gland—brain cancer	0.00292	0.00783	CbGeAlD
Levothyroxine—THRB—central nervous system—brain cancer	0.0029	0.00779	CbGeAlD
Levothyroxine—THRA—central nervous system—brain cancer	0.0029	0.00779	CbGeAlD
Levothyroxine—SLC16A2—head—brain cancer	0.00288	0.00773	CbGeAlD
Levothyroxine—THRB—cerebellum—brain cancer	0.00284	0.00761	CbGeAlD
Levothyroxine—THRA—cerebellum—brain cancer	0.00284	0.00761	CbGeAlD
Levothyroxine—SLC7A5—midbrain—brain cancer	0.0028	0.0075	CbGeAlD
Levothyroxine—THRA—Nuclear Receptors—ESR2—brain cancer	0.00279	0.0322	CbGpPWpGaD
Levothyroxine—THRB—Nuclear Receptors—ESR2—brain cancer	0.00279	0.0322	CbGpPWpGaD
Levothyroxine—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00277	0.032	CbGpPWpGaD
Levothyroxine—SLCO4A1—pituitary gland—brain cancer	0.00277	0.00743	CbGeAlD
Levothyroxine—Flushing—Procarbazine—brain cancer	0.00276	0.00962	CcSEcCtD
Levothyroxine—SLC7A5—spinal cord—brain cancer	0.00273	0.00732	CbGeAlD
Levothyroxine—TTR—midbrain—brain cancer	0.00273	0.00731	CbGeAlD
Levothyroxine—SLCO1C1—endocrine gland—brain cancer	0.00268	0.00718	CbGeAlD
Levothyroxine—SLCO4A1—medulla oblongata—brain cancer	0.00267	0.00717	CbGeAlD
Levothyroxine—TTR—spinal cord—brain cancer	0.00266	0.00713	CbGeAlD
Levothyroxine—Arrhythmia—Procarbazine—brain cancer	0.00266	0.00926	CcSEcCtD
Levothyroxine—SLCO1C1—head—brain cancer	0.00264	0.00709	CbGeAlD
Levothyroxine—Body temperature increased—Lomustine—brain cancer	0.00263	0.00917	CcSEcCtD
Levothyroxine—SLC16A2—central nervous system—brain cancer	0.00263	0.00705	CbGeAlD
Levothyroxine—Alopecia—Procarbazine—brain cancer	0.00263	0.00916	CcSEcCtD
Levothyroxine—SLC16A2—cerebellum—brain cancer	0.00257	0.00689	CbGeAlD
Levothyroxine—Affect lability—Temozolomide—brain cancer	0.00256	0.00892	CcSEcCtD
Levothyroxine—Tension—Procarbazine—brain cancer	0.00254	0.00885	CcSEcCtD
Levothyroxine—Nervousness—Procarbazine—brain cancer	0.00251	0.00876	CcSEcCtD
Levothyroxine—Mood swings—Temozolomide—brain cancer	0.00246	0.00858	CcSEcCtD
Levothyroxine—SLC7A5—endocrine gland—brain cancer	0.00246	0.00659	CbGeAlD
Levothyroxine—SLCO4A1—midbrain—brain cancer	0.00244	0.00655	CbGeAlD
Levothyroxine—SLCO1A2—telencephalon—brain cancer	0.00244	0.00653	CbGeAlD
Levothyroxine—SLC7A5—head—brain cancer	0.00243	0.00651	CbGeAlD
Levothyroxine—Tremor—Procarbazine—brain cancer	0.00243	0.00845	CcSEcCtD
Levothyroxine—Dehydration—Temozolomide—brain cancer	0.00242	0.00842	CcSEcCtD
Levothyroxine—SLCO1C1—central nervous system—brain cancer	0.00241	0.00647	CbGeAlD
Levothyroxine—TTR—endocrine gland—brain cancer	0.00239	0.00642	CbGeAlD
Levothyroxine—SLCO4A1—spinal cord—brain cancer	0.00238	0.00639	CbGeAlD
Levothyroxine—Muscular weakness—Carmustine—brain cancer	0.00237	0.00827	CcSEcCtD
Levothyroxine—TTR—head—brain cancer	0.00236	0.00634	CbGeAlD
Levothyroxine—Dysphagia—Carmustine—brain cancer	0.00232	0.0081	CcSEcCtD
Levothyroxine—THRB—brain—brain cancer	0.0023	0.00618	CbGeAlD
Levothyroxine—THRA—brain—brain cancer	0.0023	0.00618	CbGeAlD
Levothyroxine—Cardiac failure congestive—Etoposide—brain cancer	0.00229	0.00799	CcSEcCtD
Levothyroxine—Muscular weakness—Temozolomide—brain cancer	0.00229	0.00799	CcSEcCtD
Levothyroxine—Dysphagia—Temozolomide—brain cancer	0.00225	0.00783	CcSEcCtD
Levothyroxine—Convulsion—Procarbazine—brain cancer	0.00224	0.00782	CcSEcCtD
Levothyroxine—SLC7A5—central nervous system—brain cancer	0.00221	0.00594	CbGeAlD
Levothyroxine—THRA—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.00221	0.0254	CbGpPWpGaD
Levothyroxine—THRB—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.00221	0.0254	CbGpPWpGaD
Levothyroxine—Arthralgia—Procarbazine—brain cancer	0.0022	0.00768	CcSEcCtD
Levothyroxine—Anxiety—Procarbazine—brain cancer	0.0022	0.00766	CcSEcCtD
Levothyroxine—Sweating increased—Temozolomide—brain cancer	0.00219	0.00763	CcSEcCtD
Levothyroxine—THRA—Endochondral Ossification—PTCH1—brain cancer	0.00218	0.0251	CbGpPWpGaD
Levothyroxine—SLC7A5—cerebellum—brain cancer	0.00216	0.00581	CbGeAlD
Levothyroxine—TTR—central nervous system—brain cancer	0.00216	0.00579	CbGeAlD
Levothyroxine—SLCO4A1—endocrine gland—brain cancer	0.00215	0.00576	CbGeAlD
Levothyroxine—Cardiac failure—Etoposide—brain cancer	0.00213	0.00743	CcSEcCtD
Levothyroxine—Confusional state—Procarbazine—brain cancer	0.00213	0.00743	CcSEcCtD
Levothyroxine—THRB—SIDS Susceptibility Pathways—HES5—brain cancer	0.00212	0.0244	CbGpPWpGaD
Levothyroxine—SLCO4A1—head—brain cancer	0.00212	0.00568	CbGeAlD
Levothyroxine—Vomiting—Lomustine—brain cancer	0.00212	0.00737	CcSEcCtD
Levothyroxine—TTR—cerebellum—brain cancer	0.00211	0.00566	CbGeAlD
Levothyroxine—SLC16A2—brain—brain cancer	0.00209	0.0056	CbGeAlD
Levothyroxine—Shock—Procarbazine—brain cancer	0.00208	0.00725	CcSEcCtD
Levothyroxine—Tachycardia—Procarbazine—brain cancer	0.00206	0.00719	CcSEcCtD
Levothyroxine—Hyperhidrosis—Procarbazine—brain cancer	0.00204	0.00712	CcSEcCtD
Levothyroxine—Alopecia—Hydroxyurea—brain cancer	0.00203	0.00709	CcSEcCtD
Levothyroxine—Weight decreased—Temozolomide—brain cancer	0.00203	0.00708	CcSEcCtD
Levothyroxine—SLC7A5—Cell surface interactions at the vascular wall—BSG—brain cancer	0.00203	0.0234	CbGpPWpGaD
Levothyroxine—Cardiac arrest—Etoposide—brain cancer	0.00198	0.00689	CcSEcCtD
Levothyroxine—Nausea—Lomustine—brain cancer	0.00198	0.00689	CcSEcCtD
Levothyroxine—SLCO4A1—central nervous system—brain cancer	0.00193	0.00519	CbGeAlD
Levothyroxine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00192	0.00671	CcSEcCtD
Levothyroxine—SLCO1C1—brain—brain cancer	0.00192	0.00514	CbGeAlD
Levothyroxine—SLCO1A2—medulla oblongata—brain cancer	0.00191	0.00513	CbGeAlD
Levothyroxine—Insomnia—Procarbazine—brain cancer	0.00191	0.00666	CcSEcCtD
Levothyroxine—SLCO4A1—cerebellum—brain cancer	0.00189	0.00507	CbGeAlD
Levothyroxine—SLCO1B1—endocrine gland—brain cancer	0.00189	0.00506	CbGeAlD
Levothyroxine—Fatigue—Procarbazine—brain cancer	0.00182	0.00635	CcSEcCtD
Levothyroxine—Dysphagia—Etoposide—brain cancer	0.0018	0.00627	CcSEcCtD
Levothyroxine—SLC7A5—brain—brain cancer	0.00176	0.00472	CbGeAlD
Levothyroxine—Sweating increased—Etoposide—brain cancer	0.00175	0.0061	CcSEcCtD
Levothyroxine—SLCO1A2—midbrain—brain cancer	0.00175	0.00469	CbGeAlD
Levothyroxine—Feeling abnormal—Procarbazine—brain cancer	0.00174	0.00607	CcSEcCtD
Levothyroxine—Convulsion—Hydroxyurea—brain cancer	0.00174	0.00605	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Procarbazine—brain cancer	0.00173	0.00602	CcSEcCtD
Levothyroxine—Flushing—Carmustine—brain cancer	0.00173	0.00602	CcSEcCtD
Levothyroxine—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.00172	0.0198	CbGpPWpGaD
Levothyroxine—TTR—brain—brain cancer	0.00171	0.00459	CbGeAlD
Levothyroxine—SLCO1A2—spinal cord—brain cancer	0.00171	0.00458	CbGeAlD
Levothyroxine—ABCB1—blood vessel—brain cancer	0.00168	0.00451	CbGeAlD
Levothyroxine—Urticaria—Procarbazine—brain cancer	0.00168	0.00585	CcSEcCtD
Levothyroxine—Body temperature increased—Procarbazine—brain cancer	0.00167	0.00582	CcSEcCtD
Levothyroxine—Abdominal pain—Procarbazine—brain cancer	0.00167	0.00582	CcSEcCtD
Levothyroxine—Flushing—Temozolomide—brain cancer	0.00167	0.00582	CcSEcCtD
Levothyroxine—Arrhythmia—Carmustine—brain cancer	0.00166	0.00579	CcSEcCtD
Levothyroxine—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.00165	0.0191	CbGpPWpGaD
Levothyroxine—Alopecia—Carmustine—brain cancer	0.00164	0.00573	CcSEcCtD
Levothyroxine—Alopecia—Temozolomide—brain cancer	0.00159	0.00554	CcSEcCtD
Levothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.00158	0.0182	CbGpPWpGaD
Levothyroxine—Acute coronary syndrome—Etoposide—brain cancer	0.00158	0.00551	CcSEcCtD
Levothyroxine—Myocardial infarction—Etoposide—brain cancer	0.00157	0.00548	CcSEcCtD
Levothyroxine—SLCO1A2—endocrine gland—brain cancer	0.00154	0.00412	CbGeAlD
Levothyroxine—SLCO4A1—brain—brain cancer	0.00154	0.00412	CbGeAlD
Levothyroxine—Tremor—Carmustine—brain cancer	0.00152	0.00529	CcSEcCtD
Levothyroxine—SLCO1A2—head—brain cancer	0.00152	0.00407	CbGeAlD
Levothyroxine—Asthenia—Procarbazine—brain cancer	0.00152	0.00528	CcSEcCtD
Levothyroxine—Pruritus—Procarbazine—brain cancer	0.00149	0.00521	CcSEcCtD
Levothyroxine—Agitation—Carmustine—brain cancer	0.00149	0.00519	CcSEcCtD
Levothyroxine—Tremor—Temozolomide—brain cancer	0.00147	0.00511	CcSEcCtD
Levothyroxine—Dyspnoea—Hydroxyurea—brain cancer	0.00146	0.00508	CcSEcCtD
Levothyroxine—Diarrhoea—Procarbazine—brain cancer	0.00145	0.00504	CcSEcCtD
Levothyroxine—Agitation—Temozolomide—brain cancer	0.00144	0.00501	CcSEcCtD
Levothyroxine—Angioedema—Temozolomide—brain cancer	0.00143	0.00498	CcSEcCtD
Levothyroxine—Fatigue—Hydroxyurea—brain cancer	0.00141	0.00491	CcSEcCtD
Levothyroxine—Convulsion—Carmustine—brain cancer	0.0014	0.00489	CcSEcCtD
Levothyroxine—CYP2C8—pituitary gland—brain cancer	0.00139	0.00372	CbGeAlD
Levothyroxine—SLCO1A2—central nervous system—brain cancer	0.00138	0.00371	CbGeAlD
Levothyroxine—Palpitations—Temozolomide—brain cancer	0.00138	0.00482	CcSEcCtD
Levothyroxine—Anxiety—Carmustine—brain cancer	0.00137	0.00479	CcSEcCtD
Levothyroxine—Convulsion—Temozolomide—brain cancer	0.00136	0.00473	CcSEcCtD
Levothyroxine—SLCO1A2—cerebellum—brain cancer	0.00135	0.00363	CbGeAlD
Levothyroxine—Feeling abnormal—Hydroxyurea—brain cancer	0.00135	0.0047	CcSEcCtD
Levothyroxine—Vomiting—Procarbazine—brain cancer	0.00134	0.00468	CcSEcCtD
Levothyroxine—Flushing—Etoposide—brain cancer	0.00134	0.00465	CcSEcCtD
Levothyroxine—Confusional state—Carmustine—brain cancer	0.00133	0.00465	CcSEcCtD
Levothyroxine—Arthralgia—Temozolomide—brain cancer	0.00133	0.00464	CcSEcCtD
Levothyroxine—Rash—Procarbazine—brain cancer	0.00133	0.00464	CcSEcCtD
Levothyroxine—Dermatitis—Procarbazine—brain cancer	0.00133	0.00464	CcSEcCtD
Levothyroxine—Anxiety—Temozolomide—brain cancer	0.00133	0.00463	CcSEcCtD
Levothyroxine—Headache—Procarbazine—brain cancer	0.00132	0.00461	CcSEcCtD
Levothyroxine—THRA—Endochondral Ossification—SPP1—brain cancer	0.00132	0.0152	CbGpPWpGaD
Levothyroxine—Body temperature increased—Hydroxyurea—brain cancer	0.00129	0.00451	CcSEcCtD
Levothyroxine—Tachycardia—Carmustine—brain cancer	0.00129	0.0045	CcSEcCtD
Levothyroxine—Confusional state—Temozolomide—brain cancer	0.00129	0.00449	CcSEcCtD
Levothyroxine—Alopecia—Etoposide—brain cancer	0.00127	0.00443	CcSEcCtD
Levothyroxine—Nausea—Procarbazine—brain cancer	0.00125	0.00437	CcSEcCtD
Levothyroxine—Hyperhidrosis—Temozolomide—brain cancer	0.00123	0.0043	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Carmustine—brain cancer	0.0012	0.0042	CcSEcCtD
Levothyroxine—Insomnia—Carmustine—brain cancer	0.0012	0.00417	CcSEcCtD
Levothyroxine—Dyspnoea—Carmustine—brain cancer	0.00118	0.00411	CcSEcCtD
Levothyroxine—Asthenia—Hydroxyurea—brain cancer	0.00117	0.00409	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00116	0.00406	CcSEcCtD
Levothyroxine—Insomnia—Temozolomide—brain cancer	0.00116	0.00403	CcSEcCtD
Levothyroxine—Dyspnoea—Temozolomide—brain cancer	0.00114	0.00397	CcSEcCtD
Levothyroxine—Diarrhoea—Hydroxyurea—brain cancer	0.00112	0.0039	CcSEcCtD
Levothyroxine—Fatigue—Temozolomide—brain cancer	0.0011	0.00384	CcSEcCtD
Levothyroxine—SLCO1A2—brain—brain cancer	0.0011	0.00295	CbGeAlD
Levothyroxine—ALB—brain—brain cancer	0.00109	0.00293	CbGeAlD
Levothyroxine—Feeling abnormal—Carmustine—brain cancer	0.00109	0.0038	CcSEcCtD
Levothyroxine—Convulsion—Etoposide—brain cancer	0.00109	0.00378	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Carmustine—brain cancer	0.00108	0.00377	CcSEcCtD
Levothyroxine—CYP2C8—endocrine gland—brain cancer	0.00107	0.00288	CbGeAlD
Levothyroxine—SLCO1B1—Irinotecan Pathway—APC—brain cancer	0.00105	0.0122	CbGpPWpGaD
Levothyroxine—Feeling abnormal—Temozolomide—brain cancer	0.00105	0.00367	CcSEcCtD
Levothyroxine—Body temperature increased—Carmustine—brain cancer	0.00104	0.00364	CcSEcCtD
Levothyroxine—Abdominal pain—Carmustine—brain cancer	0.00104	0.00364	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Temozolomide—brain cancer	0.00104	0.00364	CcSEcCtD
Levothyroxine—Vomiting—Hydroxyurea—brain cancer	0.00104	0.00362	CcSEcCtD
Levothyroxine—Rash—Hydroxyurea—brain cancer	0.00103	0.00359	CcSEcCtD
Levothyroxine—Confusional state—Etoposide—brain cancer	0.00103	0.00359	CcSEcCtD
Levothyroxine—Dermatitis—Hydroxyurea—brain cancer	0.00103	0.00359	CcSEcCtD
Levothyroxine—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00103	0.0119	CbGpPWpGaD
Levothyroxine—Headache—Hydroxyurea—brain cancer	0.00102	0.00357	CcSEcCtD
Levothyroxine—Urticaria—Temozolomide—brain cancer	0.00101	0.00354	CcSEcCtD
Levothyroxine—Body temperature increased—Temozolomide—brain cancer	0.00101	0.00352	CcSEcCtD
Levothyroxine—Abdominal pain—Temozolomide—brain cancer	0.00101	0.00352	CcSEcCtD
Levothyroxine—Tachycardia—Etoposide—brain cancer	0.000997	0.00348	CcSEcCtD
Levothyroxine—Hyperhidrosis—Etoposide—brain cancer	0.000988	0.00344	CcSEcCtD
Levothyroxine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000979	0.0113	CbGpPWpGaD
Levothyroxine—Nausea—Hydroxyurea—brain cancer	0.000971	0.00339	CcSEcCtD
Levothyroxine—Asthenia—Carmustine—brain cancer	0.000948	0.00331	CcSEcCtD
Levothyroxine—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000922	0.0106	CbGpPWpGaD
Levothyroxine—Asthenia—Temozolomide—brain cancer	0.000916	0.00319	CcSEcCtD
Levothyroxine—Dyspnoea—Etoposide—brain cancer	0.000911	0.00318	CcSEcCtD
Levothyroxine—Diarrhoea—Carmustine—brain cancer	0.000904	0.00315	CcSEcCtD
Levothyroxine—Pruritus—Temozolomide—brain cancer	0.000904	0.00315	CcSEcCtD
Levothyroxine—THRB—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000902	0.0104	CbGpPWpGaD
Levothyroxine—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000887	0.0102	CbGpPWpGaD
Levothyroxine—Fatigue—Etoposide—brain cancer	0.000881	0.00307	CcSEcCtD
Levothyroxine—Diarrhoea—Temozolomide—brain cancer	0.000874	0.00305	CcSEcCtD
Levothyroxine—Feeling abnormal—Etoposide—brain cancer	0.000842	0.00294	CcSEcCtD
Levothyroxine—Vomiting—Carmustine—brain cancer	0.00084	0.00293	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Etoposide—brain cancer	0.000836	0.00291	CcSEcCtD
Levothyroxine—Rash—Carmustine—brain cancer	0.000833	0.0029	CcSEcCtD
Levothyroxine—Dermatitis—Carmustine—brain cancer	0.000833	0.0029	CcSEcCtD
Levothyroxine—Headache—Carmustine—brain cancer	0.000828	0.00289	CcSEcCtD
Levothyroxine—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000826	0.00952	CbGpPWpGaD
Levothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000822	0.00948	CbGpPWpGaD
Levothyroxine—ABCB1—telencephalon—brain cancer	0.000816	0.00219	CbGeAlD
Levothyroxine—SLC7A5—Hemostasis—MPL—brain cancer	0.000814	0.00939	CbGpPWpGaD
Levothyroxine—Vomiting—Temozolomide—brain cancer	0.000812	0.00283	CcSEcCtD
Levothyroxine—Urticaria—Etoposide—brain cancer	0.000812	0.00283	CcSEcCtD
Levothyroxine—Abdominal pain—Etoposide—brain cancer	0.000808	0.00282	CcSEcCtD
Levothyroxine—Body temperature increased—Etoposide—brain cancer	0.000808	0.00282	CcSEcCtD
Levothyroxine—Rash—Temozolomide—brain cancer	0.000805	0.00281	CcSEcCtD
Levothyroxine—Dermatitis—Temozolomide—brain cancer	0.000805	0.0028	CcSEcCtD
Levothyroxine—Headache—Temozolomide—brain cancer	0.0008	0.00279	CcSEcCtD
Levothyroxine—Nausea—Carmustine—brain cancer	0.000785	0.00274	CcSEcCtD
Levothyroxine—SLC7A5—Hemostasis—S100A10—brain cancer	0.000781	0.009	CbGpPWpGaD
Levothyroxine—TTR—Extracellular matrix organization—BSG—brain cancer	0.000776	0.00894	CbGpPWpGaD
Levothyroxine—CYP2C8—brain—brain cancer	0.000768	0.00206	CbGeAlD
Levothyroxine—Nausea—Temozolomide—brain cancer	0.000759	0.00264	CcSEcCtD
Levothyroxine—SLCO4C1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000739	0.00852	CbGpPWpGaD
Levothyroxine—SLCO4A1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000739	0.00852	CbGpPWpGaD
Levothyroxine—Asthenia—Etoposide—brain cancer	0.000733	0.00256	CcSEcCtD
Levothyroxine—CYP3A4—endocrine gland—brain cancer	0.000727	0.00195	CbGeAlD
Levothyroxine—Pruritus—Etoposide—brain cancer	0.000723	0.00252	CcSEcCtD
Levothyroxine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000714	0.00823	CbGpPWpGaD
Levothyroxine—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000704	0.00812	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—HES1—brain cancer	0.000701	0.00808	CbGpPWpGaD
Levothyroxine—Diarrhoea—Etoposide—brain cancer	0.000699	0.00244	CcSEcCtD
Levothyroxine—ABCB1—gonad—brain cancer	0.000681	0.00183	CbGeAlD
Levothyroxine—SLC7A5—Transmembrane transport of small molecules—S100A10—brain cancer	0.000676	0.00779	CbGpPWpGaD
Levothyroxine—ABCB1—pituitary gland—brain cancer	0.000665	0.00178	CbGeAlD
Levothyroxine—CYP3A4—central nervous system—brain cancer	0.000655	0.00176	CbGeAlD
Levothyroxine—Vomiting—Etoposide—brain cancer	0.00065	0.00227	CcSEcCtD
Levothyroxine—Rash—Etoposide—brain cancer	0.000644	0.00225	CcSEcCtD
Levothyroxine—Dermatitis—Etoposide—brain cancer	0.000644	0.00224	CcSEcCtD
Levothyroxine—ABCB1—medulla oblongata—brain cancer	0.000641	0.00172	CbGeAlD
Levothyroxine—Headache—Etoposide—brain cancer	0.00064	0.00223	CcSEcCtD
Levothyroxine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000633	0.0073	CbGpPWpGaD
Levothyroxine—THRA—Endochondral Ossification—VEGFA—brain cancer	0.000631	0.00727	CbGpPWpGaD
Levothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000629	0.00725	CbGpPWpGaD
Levothyroxine—SLCO1C1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000619	0.00714	CbGpPWpGaD
Levothyroxine—Nausea—Etoposide—brain cancer	0.000607	0.00212	CcSEcCtD
Levothyroxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000603	0.00696	CbGpPWpGaD
Levothyroxine—ABCB1—midbrain—brain cancer	0.000586	0.00157	CbGeAlD
Levothyroxine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000579	0.00667	CbGpPWpGaD
Levothyroxine—ABCB1—spinal cord—brain cancer	0.000572	0.00153	CbGeAlD
Levothyroxine—SLC7A5—Hemostasis—BSG—brain cancer	0.00055	0.00634	CbGpPWpGaD
Levothyroxine—ABCB1—endocrine gland—brain cancer	0.000515	0.00138	CbGeAlD
Levothyroxine—ABCB1—head—brain cancer	0.000508	0.00136	CbGeAlD
Levothyroxine—ABCB1—central nervous system—brain cancer	0.000464	0.00124	CbGeAlD
Levothyroxine—ABCB1—cerebellum—brain cancer	0.000453	0.00122	CbGeAlD
Levothyroxine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000401	0.00462	CbGpPWpGaD
Levothyroxine—TTR—Disease—DTX2—brain cancer	0.000389	0.00448	CbGpPWpGaD
Levothyroxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000383	0.00442	CbGpPWpGaD
Levothyroxine—THRB—Generic Transcription Pathway—ESR2—brain cancer	0.000381	0.00439	CbGpPWpGaD
Levothyroxine—THRA—Generic Transcription Pathway—ESR2—brain cancer	0.000381	0.00439	CbGpPWpGaD
Levothyroxine—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000378	0.00436	CbGpPWpGaD
Levothyroxine—ABCB1—brain—brain cancer	0.000368	0.000988	CbGeAlD
Levothyroxine—THRB—Generic Transcription Pathway—NOTCH2—brain cancer	0.000361	0.00416	CbGpPWpGaD
Levothyroxine—THRA—Generic Transcription Pathway—NOTCH2—brain cancer	0.000361	0.00416	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—TRPC6—brain cancer	0.000361	0.00416	CbGpPWpGaD
Levothyroxine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000357	0.00412	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000351	0.00405	CbGpPWpGaD
Levothyroxine—SLCO1B3—Transmembrane transport of small molecules—S100A10—brain cancer	0.000351	0.00404	CbGpPWpGaD
Levothyroxine—SLCO4C1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000341	0.00393	CbGpPWpGaD
Levothyroxine—SLCO4A1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000341	0.00393	CbGpPWpGaD
Levothyroxine—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000325	0.00375	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—OR14C36—brain cancer	0.00032	0.00369	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—OR4C12—brain cancer	0.00032	0.00369	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—MPL—brain cancer	0.000315	0.00363	CbGpPWpGaD
Levothyroxine—SLC7A5—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000312	0.0036	CbGpPWpGaD
Levothyroxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000311	0.00358	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000309	0.00357	CbGpPWpGaD
Levothyroxine—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000307	0.00354	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000306	0.00352	CbGpPWpGaD
Levothyroxine—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000303	0.00349	CbGpPWpGaD
Levothyroxine—TTR—Extracellular matrix organization—SPP1—brain cancer	0.000303	0.00349	CbGpPWpGaD
Levothyroxine—ALB—Vitamin B12 Metabolism—SOD2—brain cancer	0.00029	0.00334	CbGpPWpGaD
Levothyroxine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000289	0.00333	CbGpPWpGaD
Levothyroxine—SLCO1C1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000286	0.0033	CbGpPWpGaD
Levothyroxine—TTR—Disease—HES5—brain cancer	0.000285	0.00329	CbGpPWpGaD
Levothyroxine—SLCO1A2—Transmembrane transport of small molecules—S100A10—brain cancer	0.000276	0.00318	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—DTX2—brain cancer	0.000272	0.00314	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—VAV1—brain cancer	0.00027	0.00311	CbGpPWpGaD
Levothyroxine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.00025	0.00288	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.00024	0.00277	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—SOD2—brain cancer	0.000236	0.00272	CbGpPWpGaD
Levothyroxine—SLCO1B1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000236	0.00272	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000223	0.00258	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PTCH2—brain cancer	0.000206	0.00238	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000205	0.00237	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—DNMT1—brain cancer	0.000204	0.00236	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—DNMT1—brain cancer	0.000204	0.00236	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—HES5—brain cancer	0.0002	0.0023	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—STRADA—brain cancer	0.000194	0.00224	CbGpPWpGaD
Levothyroxine—TTR—Disease—IDH1—brain cancer	0.000192	0.00221	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—SOD2—brain cancer	0.000187	0.00216	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—ESR2—brain cancer	0.000183	0.00212	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—ESR2—brain cancer	0.000183	0.00212	CbGpPWpGaD
Levothyroxine—TTR—Disease—HEY1—brain cancer	0.000182	0.0021	CbGpPWpGaD
Levothyroxine—TTR—Disease—DLL1—brain cancer	0.000178	0.00206	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000176	0.00202	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—NOTCH2—brain cancer	0.000174	0.002	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—NOTCH2—brain cancer	0.000174	0.002	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—PIK3CG—brain cancer	0.000172	0.00198	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—PDGFRA—brain cancer	0.000171	0.00197	CbGpPWpGaD
Levothyroxine—ALB—Vitamin B12 Metabolism—RELA—brain cancer	0.000167	0.00193	CbGpPWpGaD
Levothyroxine—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000165	0.0019	CbGpPWpGaD
Levothyroxine—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000163	0.00188	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—MPL—brain cancer	0.000162	0.00187	CbGpPWpGaD
Levothyroxine—SLCO1B3—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000162	0.00187	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—ABR—brain cancer	0.000162	0.00187	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—GLI2—brain cancer	0.000156	0.0018	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—S100A10—brain cancer	0.000156	0.00179	CbGpPWpGaD
Levothyroxine—TTR—Disease—SHH—brain cancer	0.000152	0.00175	CbGpPWpGaD
Levothyroxine—TTR—Disease—ENO2—brain cancer	0.000152	0.00175	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.00015	0.00173	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—SIRT1—brain cancer	0.000148	0.0017	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—SIRT1—brain cancer	0.000148	0.0017	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—GLI1—brain cancer	0.000147	0.00169	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000142	0.00164	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—TRPC6—brain cancer	0.000139	0.00161	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—SUFU—brain cancer	0.000139	0.00161	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—RELA—brain cancer	0.000136	0.00157	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—CYP2C9—brain cancer	0.000136	0.00157	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000135	0.00156	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—S100A10—brain cancer	0.000135	0.00155	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—GFAP—brain cancer	0.000134	0.00155	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—HEY1—brain cancer	0.000127	0.00147	CbGpPWpGaD
Levothyroxine—SLCO1A2—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000127	0.00147	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—DLL1—brain cancer	0.000125	0.00144	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—IL2—brain cancer	0.000123	0.00141	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—IL2—brain cancer	0.000121	0.00139	CbGpPWpGaD
Levothyroxine—THRA—Generic Transcription Pathway—MYC—brain cancer	0.00012	0.00139	CbGpPWpGaD
Levothyroxine—THRB—Generic Transcription Pathway—MYC—brain cancer	0.00012	0.00139	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000118	0.00136	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000118	0.00136	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000117	0.00135	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—BSG—brain cancer	0.000116	0.00133	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000114	0.00131	CbGpPWpGaD
Levothyroxine—TTR—Disease—VAV1—brain cancer	0.00011	0.00126	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—BSG—brain cancer	0.00011	0.00126	CbGpPWpGaD
Levothyroxine—SLCO1B1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000109	0.00125	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—RELA—brain cancer	0.000108	0.00125	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CYP2C9—brain cancer	0.000107	0.00123	CbGpPWpGaD
Levothyroxine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	0.000107	0.00123	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—SHH—brain cancer	0.000106	0.00122	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—VAV1—brain cancer	0.000104	0.0012	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—VEGFA—brain cancer	0.000103	0.00118	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TRPC6—brain cancer	0.000102	0.00118	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PTCH1—brain cancer	0.000101	0.00116	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—SMO—brain cancer	0.000101	0.00116	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—IDH1—brain cancer	9.95e-05	0.00115	CbGpPWpGaD
Levothyroxine—TTR—Disease—HES1—brain cancer	9.43e-05	0.00109	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	9.35e-05	0.00108	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—IL2—brain cancer	9.31e-05	0.00107	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	9.17e-05	0.00106	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CYP2C9—brain cancer	9.15e-05	0.00105	CbGpPWpGaD
Levothyroxine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	9.13e-05	0.00105	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—BSG—brain cancer	9.09e-05	0.00105	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	9.06e-05	0.00104	CbGpPWpGaD
Levothyroxine—TTR—Disease—PDGFRA—brain cancer	8.98e-05	0.00103	CbGpPWpGaD
Levothyroxine—ALB—Platelet degranulation—VEGFA—brain cancer	8.94e-05	0.00103	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	8.63e-05	0.000995	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—IDH1—brain cancer	8.58e-05	0.000989	CbGpPWpGaD
Levothyroxine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	8.52e-05	0.000982	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	8.42e-05	0.000971	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.1e-05	0.000934	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—NOTCH2—brain cancer	8.05e-05	0.000928	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	8.02e-05	0.000925	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—VEGFA—brain cancer	7.91e-05	0.000912	CbGpPWpGaD
Levothyroxine—TTR—Disease—IRS2—brain cancer	7.88e-05	0.000909	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—TP53—brain cancer	7.88e-05	0.000908	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—ENO2—brain cancer	7.87e-05	0.000907	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—IDH1—brain cancer	7.82e-05	0.000902	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—BSG—brain cancer	7.78e-05	0.000897	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—TP53—brain cancer	7.75e-05	0.000894	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—VAV1—brain cancer	7.68e-05	0.000885	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—TRPC6—brain cancer	7.18e-05	0.000828	CbGpPWpGaD
Levothyroxine—TTR—Disease—APC—brain cancer	6.96e-05	0.000802	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	6.93e-05	0.000799	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—IDH1—brain cancer	6.69e-05	0.000771	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	6.63e-05	0.000764	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—HES1—brain cancer	6.6e-05	0.000761	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	6.53e-05	0.000753	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.37e-05	0.000734	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PDGFRA—brain cancer	6.29e-05	0.000725	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—TRPC6—brain cancer	6.22e-05	0.000717	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—ENO2—brain cancer	6.18e-05	0.000713	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—SPP1—brain cancer	6.1e-05	0.000703	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—MYC—brain cancer	5.79e-05	0.000667	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—MYC—brain cancer	5.79e-05	0.000667	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—IRS2—brain cancer	5.52e-05	0.000636	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	5.45e-05	0.000628	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.44e-05	0.000628	CbGpPWpGaD
Levothyroxine—TTR—Disease—ERBB2—brain cancer	5.4e-05	0.000623	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—VAV1—brain cancer	5.38e-05	0.00062	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—ENO2—brain cancer	5.29e-05	0.000609	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYP2C9—brain cancer	5.26e-05	0.000606	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYP2C9—brain cancer	5.23e-05	0.000602	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	5.07e-05	0.000584	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PIK3CG—brain cancer	4.87e-05	0.000562	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—APC—brain cancer	4.87e-05	0.000562	CbGpPWpGaD
Levothyroxine—TTR—Disease—CTNNB1—brain cancer	4.73e-05	0.000545	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	4.67e-05	0.000538	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP2C9—brain cancer	4.58e-05	0.000528	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	4.48e-05	0.000516	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—BSG—brain cancer	4.47e-05	0.000515	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—BSG—brain cancer	4.44e-05	0.000512	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	4.43e-05	0.000511	CbGpPWpGaD
Levothyroxine—TTR—Disease—STAT3—brain cancer	4.12e-05	0.000475	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	3.96e-05	0.000457	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	3.9e-05	0.00045	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—BSG—brain cancer	3.89e-05	0.000449	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—IDH1—brain cancer	3.84e-05	0.000443	CbGpPWpGaD
Levothyroxine—TTR—Disease—MYC—brain cancer	3.83e-05	0.000442	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—IDH1—brain cancer	3.82e-05	0.00044	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—RELA—brain cancer	3.81e-05	0.000439	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—ERBB2—brain cancer	3.78e-05	0.000436	CbGpPWpGaD
Levothyroxine—TTR—Disease—EGFR—brain cancer	3.75e-05	0.000432	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PIK3CG—brain cancer	3.61e-05	0.000416	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	3.59e-05	0.000414	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	3.51e-05	0.000405	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—IL2—brain cancer	3.43e-05	0.000395	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3CG—brain cancer	3.42e-05	0.000394	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—IDH1—brain cancer	3.35e-05	0.000386	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CCND1—brain cancer	3.34e-05	0.000385	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CTNNB1—brain cancer	3.31e-05	0.000382	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.13e-05	0.000361	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.11e-05	0.000359	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ENO2—brain cancer	3.04e-05	0.00035	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ENO2—brain cancer	3.02e-05	0.000348	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	2.95e-05	0.00034	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—VEGFA—brain cancer	2.91e-05	0.000336	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—STAT3—brain cancer	2.89e-05	0.000333	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CG—brain cancer	2.84e-05	0.000327	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP2C9—brain cancer	2.82e-05	0.000325	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MYC—brain cancer	2.68e-05	0.000309	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ENO2—brain cancer	2.65e-05	0.000305	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—EGFR—brain cancer	2.62e-05	0.000302	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CG—brain cancer	2.42e-05	0.00028	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—IL2—brain cancer	2.4e-05	0.000277	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—BSG—brain cancer	2.4e-05	0.000277	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TP53—brain cancer	2.2e-05	0.000254	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—IDH1—brain cancer	2.06e-05	0.000238	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—VEGFA—brain cancer	2.04e-05	0.000236	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ENO2—brain cancer	1.63e-05	0.000188	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—TP53—brain cancer	1.54e-05	0.000178	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CG—brain cancer	1.39e-05	0.000161	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CG—brain cancer	1.39e-05	0.00016	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CG—brain cancer	1.21e-05	0.00014	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CG—brain cancer	7.48e-06	8.62e-05	CbGpPWpGaD
